SavedAdd your journal

Journals / Turkish journal of emergency medicine (Online) / 2022 / Cilt: 22 - Sayı: 2

Messenger ribonucleic acid vaccine‑associated immune thrombocytopenia: A rare complication of vaccine

Betül BÖRKÜ UYSAL
Mehmet Sami İSLAMOĞLU
Mehmet GÜNDÜZ
Mehmet DOKUR
Pages
111–113
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Peripheral blood smear supported the blood count test results with thrombocytopenia, secondary causes of thrombocytopenia were excluded, and the patient was diagnosed with vaccine‑induced immune thrombocytopenia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coronavirus disease‑2019 continues to have a serious impact in countries with the effect of new variant viruses emerging with mutations.
📊
Key Findings & Data:While the effectiveness and protection of the vaccine have been determined all over the world, some vaccine‑related side effects can be detected in the form of cases.
💡
Conclusion & Impact:Peripheral blood smear supported the blood count test results with thrombocytopenia, secondary causes of thrombocytopenia were excluded, and the patient was diagnosed with vaccine‑induced immune thrombocytopenia.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Coronavirus disease‑2019 continues to have a serious impact in countries with the effect of new variant viruses emerging with mutations. While the effectiveness and protection of the vaccine have been determined all over the world, some vaccine‑related side effects can be detected in the form of cases. In our case, the patient was admitted to the emergency department of our hospital with complaints of weakness and progressive rash on his legs. Diffuse petechiae purpura on the legs of the patient was observed and complete blood count revealed thrombocytopenia. Peripheral blood smear supported the blood count test results with thrombocytopenia, secondary causes of thrombocytopenia were excluded, and the patient was diagnosed with vaccine‑induced immune thrombocytopenia.

🔖

Cite This Article

UYSAL, B. B., İSLAMOĞLU, M. S., GÜNDÜZ, M., DOKUR, M. (2022). Messenger ribonucleic acid vaccine‑associated immune thrombocytopenia: A rare complication of vaccine. Turkish journal of emergency medicine (Online), Cilt: 22 - Sayı: 2, 111–113. https://ajindex.com/articles/605195

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Aleem A, Nadeem AJ. Coronavirus (COVID‑19) vaccine‑induced immune thrombotic thrombocytopenia (VITT). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK570605/. [Last updated on 2021 Jul 18]
  2. Dooling K, Gargano JW, Moulia D, Wallace M, Rosenblum HG, Blain AE, et al. Use of Pfizer‑BioNTech COVID‑19 vaccine in persons aged≥16 years: Recommendations of the advisory committee on immunization practices – United States, September 2021. MMWR Morb Mortal Wkly Rep 2021;70:1344‑8
  3. Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID‑19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine 2021;39:3329‑32
  4. Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood 2017;129:2829‑35
  5. Lakshmanan S, Cuker A. Contemporary management of primary immune thrombocytopenia in adults. J Thromb Haemost 2012;10:1988‑98
  6. Miller E, Waight P, Farrington CP, Andrews N, Stowe J, Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child 2001;84:227‑9
  7. Bhattacharjee, S., Banerjee, M. Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review. SN Compr. Clin. Med. 2, 2048–2058 (2020).
  8. Pfizer BioNTech. Pfizer BioNTech COVID 19 Vaccine Briefing Document,Vaccines and Related Biological Products Advisory Committee Meeting December 10, 2020 https://www.fda.gov/ media/144245/download
  9. Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID‑19 vaccines: Comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and moderna vaccines. Eur Rev Med Pharmacol Sci 2021;25:1663‑9
  10. Smock KJ, Perkins SL. Thrombocytopenia: An update. Int J Lab Hematol 2014;36:269‑78
  11. Pasin F, Calabrese A, Pelagatti L. Immune thrombocytopenia following COVID 19 mRNA vaccine: Casuality or causality? Intern Emerg Med 2021 Jun 7;1-3. doi: 10.1007/s11739-02102778-w
  12. Ganzel C, Ben‑Chetrit E. Immune thrombocytopenia following the Pfizer‑BioNTech BNT162b2 mRNA COVID‑19 vaccine. Isr Med Assoc J 2021;23:341
  13. Fueyo‑Rodriguez O, Valente‑Acosta B, Jimenez‑Soto R, Neme‑Yunes Y, Inclán‑Alarcón SI, Trejo‑Gonzalez R, et al. Secondary immune thrombocytopenia supposedly attributable to COVID‑19 vaccination. BMJ Case Rep 2021;14:e242220
  14. Al‑Maqbali JS, Al Rasbi S, Kashoub MS, Al Hinaai AM, Fa